D.E. Shaw & Co’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957K | Buy |
59,818
+9,284
| +18% | +$149K | ﹤0.01% | 2241 |
|
|
2025
Q1 | $864K | Sell |
50,534
-17,135
| -25% | -$293K | ﹤0.01% | 2241 |
|
|
2024
Q4 | $1.68M | Buy |
67,669
+5,234
| +8% | +$130K | ﹤0.01% | 1890 |
|
|
2024
Q3 | $1.78M | Buy |
62,435
+20,956
| +51% | +$597K | ﹤0.01% | 1851 |
|
|
2024
Q2 | $1.1M | Sell |
41,479
-14,435
| -26% | -$381K | ﹤0.01% | 2138 |
|
|
2024
Q1 | $1.81M | Sell |
55,914
-52
| -0.1% | -$1.68K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $2.36M | Sell |
55,966
-86,598
| -61% | -$3.65M | ﹤0.01% | 1657 |
|
|
2023
Q3 | $5.47M | Sell |
142,564
-620,647
| -81% | -$23.8M | 0.01% | 1140 |
|
|
2023
Q2 | $14.5M | Buy |
763,211
+318,758
| +72% | +$6.05M | 0.01% | 701 |
|
|
2023
Q1 | $6.89M | Buy |
444,453
+145,983
| +49% | +$2.26M | 0.01% | 1152 |
|
|
2022
Q4 | $5.3M | Buy |
+298,470
| New | +$5.3M | 0.01% | 1420 |
|
|
2022
Q1 | – | Sell |
-20,371
| Closed | -$174K | – | 4353 |
|
|
2021
Q4 | $174K | Buy |
+20,371
| New | +$174K | ﹤0.01% | 3533 |
|
|
2021
Q2 | – | Sell |
-25,119
| Closed | -$403K | – | 3632 |
|
|
2021
Q1 | $403K | Buy |
+25,119
| New | +$403K | ﹤0.01% | 2576 |
|